Express News | Cardinal Health Inc : Baird Raises Target Price to $130 From $129
Leerink Adjusts Price Target on Cardinal Health to $122 From $120, Maintains Outperform Rating
Cardinal Health (CAH) has an average hold rating and a price target range of $92 to $129, according to analysts polled by Capital IQ.Price: 95.91, Change: +0.02, Percent Change: +0.02
Express News | Cardinal Health Inc : Leerink Partners Raises Target Price to $122 From $120
From Lab Rats And Eyeballs To Cannabis: Scarlet Express CEO Discusses Closed-Loop Delivery, How To 'Survive In Chaos'
First, Claudia Post oversaw the safe delivery of eyeballs, kidneys and other organs. Today? Her specialty is cannabis. Most recently, she launched Scarlet Express with financial backing from Ben Sopr
Top High Quality Stocks That Pay Dividends - UBS
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 2.37% on an annualized basis producing an average annual return of 15.18%. Currently, Cardinal Health has a market capit
Cardinal Health To Go Ex-Dividend On July 1st, 2024 With 0.5056 USD Dividend Per Share
June 27th (Eastern Time) - $Cardinal Health(CAH.US)$ is trading ex-dividend on July 1st, 2024.Shareholders of record on July 1st, 2024 will receive 0.5056 USD dividend per share on July 15th, 2024. Th
Cardinal Health (CAH) Stock Sinks As Market Gains: What You Should Know
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today
Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 4.45% on an annualized basis producing an average annual return of 17.8%. Currently, Cardinal Health has a market capita
5 Cheap Stocks Buying Back Shares at Reasonable Prices
Buybacks are in fashion. But at today's valuations, companies could be paying up for their own stock—and that's never a good idea, whether you're a CEO or a retail investor.
Mizuho Securities Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $104
Mizuho Securities analyst Ann Hynes maintains $Cardinal Health(CAH.US)$ with a hold rating, and maintains the target price at $104.According to TipRanks data, the analyst has a success rate of 57.9% a
Express News | Cardinal Health Issues Product Recall for Jiangsu Shenli Syringes Contained Within Merit Medical Kits
Cardinal Health on Pace for Largest Percent Increase Since November 2023 -- Data Talk
Cardinal Health, Inc. (CAH) is currently at $104.14, up $3.19 or 3.16% --Would be highest close since April 19, 2024, when it closed at $108.19 --On pace for largest percent increase since Nov. 3, 2
Surgical Suction Instruments Market to Hit USD 503 Million by 2029, Driven by 6.1% CAGR | MarketsandMarkets
CHICAGO, June 17, 2024 /PRNewswire/ -- The global surgical suction instruments market is projected to reach USD 503 million by 2029, growing at a CAGR of 6.1% from USD 375 million in 2024, driven by
Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056
Earnings Tell The Story For Cardinal Health, Inc. (NYSE:CAH)
With a price-to-earnings (or "P/E") ratio of 44.4x Cardinal Health, Inc. (NYSE:CAH) may be sending very bearish signals at the moment, given that almost half of all companies in the United States have
Deutsche Bank Adjusts Cardinal Health Price Target to $115 From $110
Cardinal Health (CAH) has an average rating of Hold and price targets ranging from $92 to $129, according to analysts polled by Capital IQ. Price: 101.45, Change: +0.84, Percent Change: +0.83
TD Cowen Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $109
TD Cowen analyst Charles Rhyee maintains $Cardinal Health(CAH.US)$ with a hold rating, and maintains the target price at $109.According to TipRanks data, the analyst has a success rate of 47.4% and a
Is Cardinal Health Inc (NYSE:CAH) the Best Dividend Growth Stock to Buy in 2024?
Research Alert: CFRA Raises View On Shares Of Cardinal Health Inc. To Buy From Hold
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $3 to $1